$NEPH
NEPHROS INC

2013 Form 10-K Financial Statement

#000114420414018633 Filed on March 28, 2014

View on sec.gov

Income Statement

Concept 2013 2012 Q4 2012
Revenue $1.740M $370.0K $1.807M
YoY Change -3.71% -24.49% -18.24%
Cost Of Revenue $898.0K $290.0K $737.0K
YoY Change 21.85% -12.12% -45.41%
Gross Profit $842.0K $80.00K $1.070M
YoY Change -21.31% -50.0% 22.99%
Gross Profit Margin 48.39% 21.62% 59.21%
Selling, General & Admin $3.069M $1.060M $3.620M
YoY Change -15.22% 51.43% 37.12%
% of Gross Profit 364.49% 1325.0% 338.32%
Research & Development $867.0K $80.00K $632.0K
YoY Change 37.18% 14.29% 40.44%
% of Gross Profit 102.97% 100.0% 59.07%
Depreciation & Amortization $9.000K -$90.00K $9.000K
YoY Change 0.0% -550.0% -90.0%
% of Gross Profit 1.07% -112.5% 0.84%
Operating Expenses $4.159M $1.190M $4.403M
YoY Change -5.54% 48.75% 38.9%
Operating Profit -$3.317M -$1.110M -$3.333M
YoY Change -0.48% 73.44% 44.91%
Interest Expense $351.0K $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $50.00K $10.00K $14.00K
YoY Change 257.14%
Pretax Income $1.320M -$1.100M -$3.260M
YoY Change -140.49% 71.88% 38.14%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.698M -$1.100M -$6.623M
YoY Change -44.16% 71.88% -5.36%
Net Earnings / Revenue -212.53% -297.3% -366.52%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share -$0.18 -$839.7K -$2.608M
COMMON SHARES
Basic Shares Outstanding 15.62M shares
Diluted Shares Outstanding 20.76M shares

Balance Sheet

Concept 2013 2012 Q4 2012
SHORT-TERM ASSETS
Cash & Short-Term Investments $580.0K $50.00K $50.00K
YoY Change 1060.0% -97.01% -97.01%
Cash & Equivalents $580.0K $50.00K $50.00K
Short-Term Investments
Other Short-Term Assets $130.0K $109.0K $110.0K
YoY Change 18.18% -0.91% -8.33%
Inventory $160.0K $312.0K $310.0K
Prepaid Expenses
Receivables $120.0K $940.0K $940.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $990.0K $1.403M $1.400M
YoY Change -29.29% -56.16% -56.25%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $16.00K $20.00K
YoY Change -50.0% -20.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.890M $2.109M $2.110M
YoY Change -10.43%
Total Long-Term Assets $1.900M $2.125M $2.130M
YoY Change -10.8% 168.99% 169.62%
TOTAL ASSETS
Total Short-Term Assets $990.0K $1.403M $1.400M
Total Long-Term Assets $1.900M $2.125M $2.130M
Total Assets $2.890M $3.528M $3.530M
YoY Change -18.13% -11.58% -11.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.070M $1.070M $2.390M
YoY Change -55.23% 282.14% 753.57%
Accrued Expenses $370.0K $321.0K $320.0K
YoY Change 15.63% 60.5% 60.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.360M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.500M $3.416M $3.420M
YoY Change 2.34% 189.49% 189.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.110M $710.0K $710.0K
YoY Change 338.03% -49.29% -49.29%
Total Long-Term Liabilities $3.110M $710.0K $710.0K
YoY Change 338.03% -49.29% -49.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.500M $3.416M $3.420M
Total Long-Term Liabilities $3.110M $710.0K $710.0K
Total Liabilities $6.610M $4.123M $4.120M
YoY Change 60.44% 60.43% 60.31%
SHAREHOLDERS EQUITY
Retained Earnings -$108.1M
YoY Change 6.53%
Common Stock $12.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.720M -$595.0K -$600.0K
YoY Change
Total Liabilities & Shareholders Equity $2.890M $3.528M $3.530M
YoY Change -18.13% -11.58% -11.53%

Cashflow Statement

Concept 2013 2012 Q4 2012
OPERATING ACTIVITIES
Net Income -$3.698M -$1.100M -$6.623M
YoY Change -44.16% 71.88% -5.36%
Depreciation, Depletion And Amortization $9.000K -$90.00K $9.000K
YoY Change 0.0% -550.0% -90.0%
Cash From Operating Activities -$3.580M -$460.0K -$1.550M
YoY Change 130.97% -25.81% 19.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $10.00K $8.000K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $50.00K $50.00K
YoY Change -100.0%
Cash From Investing Activities $0.00 $60.00K -$610.0K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.771M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.120M 50.00K 500.0K
YoY Change 724.0% -70.59% -81.62%
NET CHANGE
Cash From Operating Activities -3.580M -460.0K -1.550M
Cash From Investing Activities 0.000 60.00K -610.0K
Cash From Financing Activities 4.120M 50.00K 500.0K
Net Change In Cash 540.0K -350.0K -1.660M
YoY Change -132.53% -22.22% -216.9%
FREE CASH FLOW
Cash From Operating Activities -$3.580M -$460.0K -$1.550M
Capital Expenditures $0.00 $10.00K $8.000K
Free Cash Flow -$3.580M -$470.0K -$1.558M
YoY Change 129.78% -24.19% 19.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Cash
Cash
579000 USD
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
122000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
162000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
125000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
988000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1894000 USD
CY2013Q4 us-gaap Assets
Assets
2889000 USD
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18082043 shares
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3499000 USD
CY2012Q4 us-gaap Cash
Cash
47000 USD
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
935000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
312000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
109000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1403000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2109000 USD
CY2012Q4 us-gaap Assets
Assets
3528000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
321000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
707000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3416000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-3262000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-3698000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3235000 USD
CY2012Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1318000 USD
CY2013Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
0 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
365000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
703000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
707000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2012Q4 us-gaap Liabilities
Liabilities
4123000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
3499000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96847000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
100526000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
76000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97530000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101228000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-595000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-610000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3528000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2889000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="COLOR: black"><font style="FONT-SIZE: 10pt">Use of Estimates in the Preparation of Financial Statements</font></font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="COLOR: black"><font style="FONT-SIZE: 10pt"> &#160;</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of <font style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt"> consolidated&#160;</font> financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements, and the reported amount of revenues and expenses, during the reporting period. Actual results could differ materially from those estimates.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Certain prior year amounts have been reclassified to conform to the current year presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black"><font style="FONT-SIZE: 10pt"><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Impairment for Long-Lived Assets</strong></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black"><font style="FONT-SIZE: 10pt">&#160;</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in" align="justify"><font style="COLOR: black"><font style="FONT-SIZE: 10pt">The Company adheres to Accounting Standards Codification (&#8220;ASC&#8221;) Topic 360 and periodically evaluates whether current facts or circumstances indicate that the carrying value of its depreciable assets to be held and used may be recoverable. If such circumstances are determined to exist, an estimate of undiscounted future cash flows produced by the long-lived assets, or the appropriate grouping of assets, is compared to the carrying value to determine whether impairment exists. If an asset is determined to be impaired, the loss is measured based on the difference between the asset&#8217;s fair value and its carrying value. An estimate of the asset&#8217;s fair value is based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. The Company reports an asset to be disposed of at the lower of its carrying value or its estimated net realizable market value. There were no impairment losses for long-lived assets recorded for the years ended December 31, 2013 and December 31, 2012.</font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
269000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
365000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11949824 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18082043 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11949824 shares
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2012 us-gaap Interest Expense
InterestExpense
0 USD
CY2013 us-gaap Interest Expense
InterestExpense
94000 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
257000 USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55000 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1127000 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1029000 USD
CY2012 us-gaap Licenses Revenue
LicensesRevenue
680000 USD
CY2013 us-gaap Licenses Revenue
LicensesRevenue
711000 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
1807000 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
1740000 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
737000 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
898000 USD
CY2012 us-gaap Gross Profit
GrossProfit
1070000 USD
CY2013 us-gaap Gross Profit
GrossProfit
842000 USD
CY2012 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
632000 USD
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
826000 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
151000 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
223000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3620000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3110000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
4403000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
4159000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-3333000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-3317000 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33000 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
27000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3700000 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11223878 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15624999 shares
CY2012 neph Number Of Major Customers
NumberOfMajorCustomers
3 pure
CY2013 neph Number Of Major Customers
NumberOfMajorCustomers
3 pure
CY2012Q4 us-gaap Inventory Gross
InventoryGross
581000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
527000 USD
CY2013Q4 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
356000 USD
CY2012 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
142000 USD
CY2013 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
214000 USD
CY2013Q4 neph Finite Lived Intangible Assets Amortization Expense Years Two And Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearsTwoAndThree
208000 USD
CY2013 neph Royalty Rate
RoyaltyRate
0.03 pure
CY2012Q2 neph Employment Agreement Term
EmploymentAgreementTerm
P4Y
CY2012Q2 neph Employment Agreement Annual Salary
EmploymentAgreementAnnualSalary
350000 USD
CY2012Q2 neph Employment Agreement Discretionary Bonus Percentage
EmploymentAgreementDiscretionaryBonusPercentage
0.3 pure
CY2013Q4 neph Operating Lease Monthly Rent Expense
OperatingLeaseMonthlyRentExpense
8000 USD
CY2013Q3 neph Lease Extension Term
LeaseExtensionTerm
P1Y
CY2013Q3 neph Operating Lease Monthly Rent Expense Renewal Amount
OperatingLeaseMonthlyRentExpenseRenewalAmount
8000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
109000 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
108000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1421000 USD
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
27000 USD
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 USD
CY2013 neph Stock Issued During Period Value Shareholder Rights Offering
StockIssuedDuringPeriodValueShareholderRightsOffering
2771000 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
503000 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
248000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
443000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
652000 USD
CY2013 neph Adjustments To Additional Paid In Capital Warrant Incremental Fair Value Of Inducement
AdjustmentsToAdditionalPaidInCapitalWarrantIncrementalFairValueOfInducement
14000 USD
CY2012 neph Stock Issued During Period Related To Licensing Agreement Value
StockIssuedDuringPeriodRelatedToLicensingAgreementValue
273000 USD
CY2013 neph Number Of Products In Development
NumberOfProductsInDevelopment
2 Product
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
1414000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
703000 USD
CY2012Q1 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
2459000 USD
CY2013Q1 neph Receivable For License Agreement
ReceivableForLicenseAgreement
791000 USD
CY2012 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
33000 USD
CY2013 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
30000 USD
CY2013 neph Other Income Adjustments To Liabilities And Foreign Currency Losses
OtherIncomeAdjustmentsToLiabilitiesAndForeignCurrencyLosses
36000 USD
CY2012Q4 us-gaap Prepaid Insurance
PrepaidInsurance
78000 USD
CY2013Q4 us-gaap Prepaid Insurance
PrepaidInsurance
70000 USD
CY2012Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
21000 USD
CY2013Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
21000 USD
CY2012Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
10000 USD
CY2013Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
34000 USD
CY2012 us-gaap Depreciation
Depreciation
9000 USD
CY2012 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
42500 EUR
CY2012 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
55000 USD
CY2012 neph Proceeds From Sale Of Machinery And Equipment Amount Recognized In Other Income
ProceedsFromSaleOfMachineryAndEquipmentAmountRecognizedInOtherIncome
42500 EUR
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
237315 shares
CY2012 neph Proceeds From Sale Of Machinery And Equipment Amount Recognized In Other Income
ProceedsFromSaleOfMachineryAndEquipmentAmountRecognizedInOtherIncome
55000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
737000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
734000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
721000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
727000 USD
CY2012Q4 neph Accrued Professional Fees Current Legal
AccruedProfessionalFeesCurrentLegal
90000 USD
CY2013Q4 neph Accrued Professional Fees Current Legal
AccruedProfessionalFeesCurrentLegal
149000 USD
CY2012Q4 neph Accrued Compensation Current
AccruedCompensationCurrent
77000 USD
CY2013Q4 neph Accrued Compensation Current
AccruedCompensationCurrent
0 USD
CY2012Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
0 USD
CY2013Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
81000 USD
CY2012Q4 neph Accrued Travel Expenses Current
AccruedTravelExpensesCurrent
84000 USD
CY2013Q4 neph Accrued Travel Expenses Current
AccruedTravelExpensesCurrent
0 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
70000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36000 USD
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0536 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0522 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0078 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0040 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0106 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0109 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0229 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0300 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3835 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3871 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25721000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27029000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1054000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1096000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1701000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1801000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
441000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
408000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
28917000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30334000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28917000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30334000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9000 USD
CY2012 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
142000 USD
CY2013 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
214000 USD
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
443000 USD
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
575000 USD
CY2012 neph Noncash Warrant Inducement
NoncashWarrantInducement
0 USD
CY2013 neph Noncash Warrant Inducement
NoncashWarrantInducement
14000 USD
CY2012 neph Inventory Fifo Reserve Period Charge
InventoryFifoReservePeriodCharge
82000 USD
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2013 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-39000 USD
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
659000 USD
CY2013 neph Inventory Fifo Reserve Period Charge
InventoryFifoReservePeriodCharge
210000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
55000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7000 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-26000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1006000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-820000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
147000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
60000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16000 USD
CY2012 us-gaap Increase Decrease In Long Term Receivables Current
IncreaseDecreaseInLongTermReceivablesCurrent
0 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
904000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
59000 USD
CY2012 neph Increase Decrease In License And Supply Agreement Fee Payable
IncreaseDecreaseInLicenseAndSupplyAgreementFeePayable
0 USD
CY2013 neph Increase Decrease In License And Supply Agreement Fee Payable
IncreaseDecreaseInLicenseAndSupplyAgreementFeePayable
-1318000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-680000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-711000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1547000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3583000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-612000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3000 USD
CY2012 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
399000 USD
CY2012 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
503000 USD
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
248000 USD
CY2013 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2800000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2771000 USD
CY2012 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
CY2013 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1300000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
503000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4120000 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
34000 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-8000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1622000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
532000 USD
CY2011Q4 us-gaap Cash
Cash
1669000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
18000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000 USD
CY2012 neph Restricted Stock Shares Issued To Settle Liability
RestrictedStockSharesIssuedToSettleLiability
0 USD
CY2013 neph Restricted Stock Shares Issued To Settle Liability
RestrictedStockSharesIssuedToSettleLiability
77000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1318000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
0 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
791000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
0 USD
CY2012 neph Share Based Goods And Nonemployee Services Transaction Fair Market Value Of Options Granted
ShareBasedGoodsAndNonemployeeServicesTransactionFairMarketValueOfOptionsGranted
273000 USD
CY2013 neph Share Based Goods And Nonemployee Services Transaction Fair Market Value Of Options Granted
ShareBasedGoodsAndNonemployeeServicesTransactionFairMarketValueOfOptionsGranted
0 USD
CY2012 neph Sharebased Compensation Arrangement By Share Based Payment Award Options Term
SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsTerm
P10Y
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
443000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
418000 USD
CY2012 neph Allocated Share Based Compensation Expense Per Share
AllocatedShareBasedCompensationExpensePerShare
0.04 pure
CY2013 neph Allocated Share Based Compensation Expense Per Share
AllocatedShareBasedCompensationExpensePerShare
0.03 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
506000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
519000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1547550 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.03
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.56
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
793000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
768000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
727000 USD
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.45
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.45
CY2012 neph Warrants Exercised
WarrantsExercised
23720667 shares
CY2013 neph Warrants Exercised
WarrantsExercised
2254500 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2410134 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.28
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1385199 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.46
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2294714 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2410134 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2350688 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1385199 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.14
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.64
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.29
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.46
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
14679971 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13887598 shares
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.15 pure
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
49000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
46000 USD
CY2013Q4 us-gaap Contractual Obligation
ContractualObligation
896000 USD
CY2013Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
450000 USD
CY2013Q4 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
446000 USD
CY2013Q4 us-gaap Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
0 USD
CY2013Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
0 USD
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
229000 USD
CY2012Q4 neph Senior Secured Note Payable Net Of Discount
SeniorSecuredNotePayableNetOfDiscount
0 USD
CY2013Q4 neph Senior Secured Note Payable Net Of Discount
SeniorSecuredNotePayableNetOfDiscount
1358000 USD
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
121895 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.27
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
NEPH
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25225704 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
NEPHROS INC
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001196298
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
10181000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2012 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2013 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2012 us-gaap Sales Returns And Allowances Goods
SalesReturnsAndAllowancesGoods
0 USD
CY2013 us-gaap Sales Returns And Allowances Goods
SalesReturnsAndAllowancesGoods
0 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2013Q4 neph Accrued Product Recall
AccruedProductRecall
60000 USD
CY2012Q4 neph Accrued Interest Current
AccruedInterestCurrent
0 USD
CY2013Q4 neph Accrued Interest Current
AccruedInterestCurrent
39000 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
4000 USD
CY2013Q4 neph Note Payable Net Of Discount
NotePayableNetOfDiscount
142000 USD
CY2013 us-gaap Interest And Other Income
InterestAndOtherIncome
17000 USD
CY2013 us-gaap Other Expenses
OtherExpenses
50000 USD
CY2013Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1300000 USD
CY2012 neph Other Income Write Off
OtherIncomeWriteOff
18000 USD
CY2012 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
4000 USD
CY2013 neph Additional Shares Not Issued Results Of Warrants Exercised
AdditionalSharesNotIssuedResultsOfWarrantsExercised
374 shares
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
53000 USD
CY2013Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
204000 USD
CY2013Q1 neph Authorised Value Of Rights Offering
AuthorisedValueOfRightsOffering
3000000 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.18776 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.60
CY2013Q2 neph Class Of Warrant Or Right Issued Shares
ClassOfWarrantOrRightIssuedShares
5000000 shares
CY2013Q2 neph Class Of Warrant Or Right Issued Gross Value Received
ClassOfWarrantOrRightIssuedGrossValueReceived
3000000 USD
CY2013Q2 neph Class Of Warrant Or Right Issued Net Value Received
ClassOfWarrantOrRightIssuedNetValueReceived
1400000 USD
CY2013Q2 neph Repayments Of Senior Secured Note
RepaymentsOfSeniorSecuredNote
1300000 USD
CY2013Q2 neph Repayments Of Accrued Interest On Senior Secured Note
RepaymentsOfAccruedInterestOnSeniorSecuredNote
46800 USD
CY2013Q2 neph Reimbursement Of Legal Fee
ReimbursementOfLegalFee
100000 USD
CY2013Q2 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
104000 USD

Files In Submission

Name View Source Status
0001144204-14-018633-index-headers.html Edgar Link pending
0001144204-14-018633-index.html Edgar Link pending
0001144204-14-018633.txt Edgar Link pending
0001144204-14-018633-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
neph-20131231.xml Edgar Link completed
neph-20131231.xsd Edgar Link pending
neph-20131231_cal.xml Edgar Link unprocessable
neph-20131231_def.xml Edgar Link unprocessable
neph-20131231_lab.xml Edgar Link unprocessable
neph-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v367659_10k.htm Edgar Link pending
v367659_ex23-1.htm Edgar Link pending
v367659_ex31-1.htm Edgar Link pending
v367659_ex32-1.htm Edgar Link pending